This Week’s Biotech Highlights
The world of biotech was all shook up this week:
In venture capital, GrowthWorks was stepping on Covington’s Blue Suede Shoes by soliciting votes against Convington’s planned acquisition of the VenGrowth funds, saying it wants time to make its own offer. The CPPIB handed a Big Hunk O’ Love to NorthLeaf Capital, turning over management of its $438 million portfolio of venture capital investments including Celtic, Edgestone, Lumira/MDS, Skypoint and Ventures West.
Meanwhile, Dr. Mick Bhatia’s group at the Stem Cell and Cancer Research Institute at McMaster University found a way to make human skin cells sing “Any Way . . . [more]


